Medscape has published an overview to the 2024 updated recommendations for the treatment of systemic sclerosis (SSc) presented in Vienna at EULAR 2024 by Professor Francesco Del Galdo, MD, PhD on behalf of a 27 member task force.
Read Article
Johns Hopkins Hospital in Baltimore has been named the top hospital for rheumatology by U.S. News & World Report. This is the 7th year in a row they have held this spot.
Read Article
Editor's note: This article originally appeared April 16, 2024, and is being shared again while RheumNow enjoys the July 4th holiday. Enjoy!
Read Article
Editor's note: This article originally appeared March 12, 2024, and is being shared again while RheumNow enjoys the July 4th holiday. Enjoy!
Read Article
A retrospective cohort study of biological disease-modifying antirheumatic drugs (bDMARDs) persistence in rheumatoid arthritis (RA) patients with chronic kidney disease (CKD), shows the 3 year survicval to be under 50% but that all studied biologics were nearly equivalent
Systemic sclerosis sine scleroderma (ssSSc), which accounts for nearly 10% of systemic sclerosis (SSc) patients and was first described in 1962, is a subset o
Editor's note: This article originally appeared April 9, 2024, and is being shared again while RheumNow enjoys the July 4th holiday. Enjoy!
Read Article
Editor's note: This article originally appeared March 21, 2024, and is being shared again while RheumNow enjoys the July 4th holiday. Enjoy!
Read Article
A study from the University of British Columbia has evaluated the trajectories of hydroxychloroquine (HCQ) use in patients with incident RA and SLE between1997 and 2021, and identified factors associated with high adherence.
Read Article
A study from the Leiden Early Arthritis Clinic shows that is rheumatoid arthritis (RA) is diagnosed within 12 weeks after symptom onset, treatment costs were lower in both autoantibody-negative and autoantibody-positive RA.
Editor's note: This article originally appeared January 16, 2024, and is being shared again while RheumNow enjoys the July 4th holiday. Enjoy!
Read Article
Among women followed for upwards of 25 years, those who ate relatively large amounts of "ultraprocessed" foods -- such as soft drinks, frozen pizzas, and mass-produced baked goods -- developed systemic lupus erythematosus (SLE) at more than 50% greater rates than those with relatively low consump
Read Article
Autoimmune liver diseases (ALDs), including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC), are complex conditions involving the liver's immune-mediated damage.
Read Article
This week on the RheumNow Podcast, Dr. Jack Cush reviews the news and journal reports of interesting, including irAE, pollution and Psoriasis, microwave therapy, scleroderma without scleroderma that only the best rheumatologists could discern.
Read Article
Editor's note: This article originally appeared January 4, 2024, and is being shared again while RheumNow enjoys the July 4th holiday. Enjoy!
Read Article
Editor's note: This article originally appeared January 26, 2024, as a bonus lecture provided to RheumNow Live 2024 registrants, and is being shared again while RheumNow enjoys the July 4th holiday.
Read Article
Editor's note: This article originally appeared March 12, 2024, and is being shared again while RheumNow enjoys the July 4th holiday. Enjoy!
Read Article
An economic evaluation of 25 099 rheumatoid arthritis patients found that treatment with biosimilar disease-modifying antirheumatic drugs (DMARDs) were cost-effective compared with the conventional DMARD, leflunomide.
Read Article
Two prominent medical journals this week published new insights into the pathogenesis of systemic lupus erythematosus (SLE), with both inidicating promient roles for T cells in what is a classically viewed as a humoral (B cell) disorder.
Read Article
